Showing results (581-590 of 612) with videos related to
Sort By:
Pageof 62
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 12, 2025
Satralizumab treatment in adults with aquaporin-4 immunoglobulin G-seropositive neuromyelitis optica spectrum disorder in clinical practiceHesham Abboud, Brian Steingo, Diana Vargas, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 28, 2025
Retinal ganglion cell loss is associated with multimodal visual dysfunction following demyelinating optic neuritisMustafa Subhi, Sargis Manukyan, Gabriela Zabala, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 9, 2025
Barriers to care for people with unclear visual loss-Data from a tertiary-level-of-care neuroinflammation centerMurat Delikaya, Charlotte Bereuter, Jan Schroeter, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 13, 2023
Humoral immune response after Ad26.COV2.S vaccination in patients with multiple sclerosis treated with natalizumabMark Gudesblatt, Myassar Zarif, Barbara Bumstead, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 29, 2023
Identifying the white matter pathways involved in multiple sclerosis-related tremor using diffusion tensor imagingAhmed Bayoumi, Khader M Hasan, Jorge Patino, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 27, 2024
Illness representation in patients with multiple sclerosis: A preliminary narrative medicine studyT Paolucci, M Reho, C Ciacchella, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 9, 2023
Adverse childhood experiences in early life increase the odds of depression among adults with multiple sclerosisKarla S Guerrero, Mary K Horton, Vidhu Choudhary, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 9, 2023
Real-world treatment outcomes and safety of natalizumab in Finnish multiple sclerosis patientsAuli Verkkoniemi-Ahola, Päivi Hartikainen, Katja Hassi, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 2, 2023
The socioeconomic impact of disability progression in multiple sclerosis: A retrospective cohort study of the German NeuroTransData (NTD) registryPaul Dillon, Yanic Heer, Eleni Karamasioti, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 29, 2023
Functional connectome fingerprinting and stability in multiple sclerosisMaron Mantwill, Susanna Asseyer, Claudia Chien, et al.Pageof 62